Preparation of Microcrystalline Glucose Transporter 1 Inhibitor BAY-876 and Its Anti-tumor Effect in Vivo / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 303-311, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-858070
ABSTRACT
OBJECTIVE:
To prepare the microcrystalline glucose transporter-1(GLUT-1)inhibitor BAY-876 and determine its pharmacological properties and examine the slow-release characteristics and in vivo anti-tumor efficiency of BAY-876-microcrystal on mice liver tumor model.METHODS:
The tumor model of HCC cells in liver of nude mice was established. The model mice were administrated BAY-876 by means of intragastric administration for three days, and then the liver of mice were photographed and examined by PET / CT. The solubilizing solution or microcrystalline BAY-876 was prepared. BAY-876-solution or microcrystal was injected into subcutaneous tumors. Blood and tumor tissue were taken from mice at different times, and the content of BAY-876 was detected. On this basis, BAY-876-solution or microcrystal was injected into the tumor in liver of nude mice, and the livers were tested by PET / CT at different times.RESULTS:
BAY-876-microcrystal can inhibit the cell growth of HCC cells. BAY-876-microcrystal can take long-term effect and slow-release in tissue. A single administration of BAY-876 in HCC liver can achieve the inhibition of HCC tumorsCONCLUSION:
The microcrystal BAY-876 is prepared, which can long-term inhibit the tumor growth in liver of nude mice.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Chinese Pharmaceutical Journal
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS